Evelo Biosciences Inc (EVLO)
0.06
0.00 (0.00%)
USD |
OTCM |
Jun 24, 16:00
Evelo Biosciences Enterprise Value: 17.82M for June 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 24, 2024 | 17.82M |
| June 21, 2024 | 17.82M |
| June 20, 2024 | 17.82M |
| June 18, 2024 | 17.82M |
| June 17, 2024 | 17.82M |
| June 14, 2024 | 17.82M |
| June 13, 2024 | 17.82M |
| June 12, 2024 | 17.82M |
| June 11, 2024 | 16.70M |
| June 10, 2024 | 16.70M |
| June 07, 2024 | 16.70M |
| June 06, 2024 | 16.70M |
| June 05, 2024 | 16.70M |
| June 04, 2024 | 16.70M |
| June 03, 2024 | 16.70M |
| May 31, 2024 | 16.70M |
| May 30, 2024 | 16.70M |
| May 29, 2024 | 16.70M |
| May 28, 2024 | 16.70M |
| May 24, 2024 | 16.70M |
| May 23, 2024 | 16.70M |
| May 22, 2024 | 16.70M |
| May 21, 2024 | 16.70M |
| May 20, 2024 | 16.70M |
| May 17, 2024 | 17.45M |
| Date | Value |
|---|---|
| May 16, 2024 | 17.61M |
| May 15, 2024 | 17.46M |
| May 14, 2024 | 17.64M |
| May 13, 2024 | 17.44M |
| May 10, 2024 | 17.63M |
| May 09, 2024 | 17.52M |
| May 08, 2024 | 17.52M |
| May 07, 2024 | 17.58M |
| May 06, 2024 | 17.59M |
| May 03, 2024 | 17.51M |
| May 02, 2024 | 17.62M |
| May 01, 2024 | 17.59M |
| April 30, 2024 | 17.62M |
| April 29, 2024 | 17.48M |
| April 26, 2024 | 17.62M |
| April 25, 2024 | 17.55M |
| April 24, 2024 | 17.52M |
| April 23, 2024 | 17.49M |
| April 22, 2024 | 17.51M |
| April 19, 2024 | 17.62M |
| April 18, 2024 | 17.63M |
| April 17, 2024 | 17.52M |
| April 16, 2024 | 17.56M |
| April 15, 2024 | 17.54M |
| April 12, 2024 | 17.64M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
14.95M
Minimum
Mar 30 2023
917.77M
Maximum
Feb 08 2021
201.28M
Average
146.01M
Median
Sep 09 2020
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 515.43M |
| Electromed Inc | 113.36M |
| Xtant Medical Holdings Inc | 104.19M |
| Asensus Surgical Inc | 80.25M |
| Myomo Inc | 79.52M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -12.36M |
| Total Expenses (Quarterly) | 10.39M |
| EPS Diluted (Quarterly) | -1.42 |
| Earnings Yield | -23.33K% |